EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


Man hand with Apple Watch and app Icon on screen

Advances

Could an Apple smart watch track your Parkinson’s disease symptoms?

Researchers hope the innovation could be used to support clinicians

READ MORE
The cast and crew of the film 'STAGES' stand aside the film poster

Europe

STAGES: “an honest and human portrayal of Parkinson’s”

We hear what the cast and crew learnt about the condition

READ MORE

Europe

Heinz Becker MEP: “Europe must take action for people with Parkinson’s”

My PD Journey will remove hurdles to optimal Parkinson's treatment

READ MORE